Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
67 studies found for:    "Kidney Neoplasms" AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
"Kidney Neoplasms" AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
Conditions: Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Tobacco Use Disorder
Interventions: Behavioral: Smoking Prevention Usual Care;   Behavioral: Counseling Intervention
2 Completed Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Conditions: Neoplasms;   Neoplasms, Glandular and Epithelial;   Neoplasms by Histologic Type;   Bronchial Neoplasms;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Digestive System Neoplasms;   Endocrine Gland Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Lung Diseases;   Breast Neoplasms;   Breast Diseases;   Renal Neoplasm;   Solid Tumors
Interventions: Drug: Entinostat;   Other: Placebo
3 Recruiting Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma;   Hereditary Leiomyomatosis and Renal Cell Cancer;   Papillary Renal Cell Carcinoma, Sporadic
Interventions: Drug: Vandetanib;   Drug: Metformin
4 Completed Brivanib Metastatic Renal Cell Carcinoma
Condition: Male and Female Subjects 18 Years of Age and Older With Metastatic Renal Cell Carcinoma. Eligible Patients Must Have Undergone and Failed Prior Treatment.
Interventions: Drug: Brivanib alaninate;   Genetic: Polymerase chain reaction;   Other: Iodine I 124 chimeric monoclonal antibody G250;   Procedure: Positron emission tomography/computed tomography;   Genetic: Protein expression analysis;   Other: Immunohistochemistry
5 Completed
Has Results
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
Conditions: Lung Neoplasms;   Ovarian Neoplasms;   Cervix Neoplasms;   Renal Neoplasms
Interventions: Drug: docetaxel;   Drug: tariquidar;   Other: 99mTc-sestamibi imaging
6 Completed Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
Conditions: Sarcoma;   Multiple Myeloma;   Testicular Neoplasms;   Ovarian Neoplasms;   Kidney Neoplasms
Intervention: Procedure: Positron Emission Tomography
7 Completed A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing
Conditions: Breast Cancer;   Ovarian Cancer;   Prostate Cancer;   Colon Cancer;   Renal Cancer
Intervention: Drug: Cyclophosphamide & ZYC300 (ZYC300 with cyclophosphamide pre-dosing)
8 Completed Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors
Conditions: Cervical Cancer;   HEENT Cancer;   Renal Cancer;   Uterine Cancer;   CERVIX UTERI NOS;   RECTUM
Intervention: Radiation: 124I-Iodo-Azomycin Galacto-Pyranoside
9 Completed Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
10 Completed Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2
Conditions: Breast Neoplasm;   Pancreatic Neoplasm;   Lung Neoplasm;   Ovarian Neoplasm;   Renal Neoplasm
Intervention: Drug: TAK-165
11 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
12 Completed Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: conventional surgery
13 Recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736
14 Completed Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Breast Cancer;   Endometrial Cancer;   Kidney Cancer;   Lung Cancer;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: metformin hydrochloride;   Drug: temsirolimus
15 Suspended Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Conditions: Adult Liver Carcinoma;   Breast Carcinoma;   Colon Carcinoma;   Kidney Neoplasm;   Lung Carcinoma;   Malignant Head and Neck Neoplasm;   Malignant Neoplasm;   Melanoma;   Ovarian Neoplasm;   Soft Tissue Sarcoma
Interventions: Procedure: Hyperthermia Treatment;   Other: Laboratory Biomarker Analysis
16 Active, not recruiting
Has Results
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
Conditions: Ovarian Cancer;   Renal Cancer;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Solid Tumors;   Multiple Myeloma;   Lymphoma
Interventions: Drug: Carfilzomib;   Drug: Dexamethasone
17 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
18 Completed
Has Results
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Conditions: Anemia;   Breast Cancer;   Cancer;   Colorectal Cancer;   Lung Cancer;   Ovarian Cancer;   Prostate Cancer;   Solid Tumors;   Bladder Cancer;   Endometrial Cancer;   Renal Cancer;   Pancreatic Cancer;   Esophageal Cancer;   Gastric Cancer
Intervention:
19 Completed Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Conditions: Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Sarcoma
Interventions: Drug: bortezomib;   Drug: gemcitabine hydrochloride
20 Active, not recruiting Survivorship Promotion In Reducing IGF-1 Trial
Conditions: Breast Cancer;   Prostate Cancer;   Lung Cancer;   Colon Cancer;   Melanoma of Skin;   Endometrial Cancer;   Liver Cancer;   Pancreatic Cancer;   Rectal Cancer;   Kidney Cancer;   Other Solid Malignant Tumors
Interventions: Drug: Metformin;   Behavioral: Coach Directed Behavioral Weight Loss;   Behavioral: Self-control weight loss

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.